SB 290157 trifluoroacetate salt
| Title | Journal |
|---|---|
| Potent heterocyclic ligands for human complement c3a receptor. | Journal of medicinal chemistry 20141023 |
| Complement C3a binding to its receptor as a negative modulator of Th2 response in liver injury in trichloroethylene-sensitized mice. | Toxicology letters 20140817 |
| Role of complement 3a in the synthetic phenotype and angiotensin II-production in vascular smooth muscle cells from spontaneously hypertensive rats. | American journal of hypertension 20120301 |
| Establishment and characterization of a murine model for allergic asthma using allergen-specific IgE monoclonal antibody to study pathological roles of IgE. | Immunology letters 20120130 |
| Effect of the C3a-receptor antagonist SB 290157 on anti-OVA polyclonal antibody-induced arthritis. | Journal of pharmacological sciences 20100101 |
| Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhage. | Brain research 20091028 |
| Complement factors C3a and C5a have distinct hemodynamic effects in the rat. | International immunopharmacology 20090601 |
| C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. | Journal of the American Society of Nephrology : JASN 20090301 |
| C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20080501 |
| Complement inhibitors selectively attenuate injury following administration of cobra venom factor to rats. | International immunopharmacology 20060801 |
| The C3a receptor antagonist SB 290157 has agonist activity. | Immunology letters 20050915 |
| Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis. | Journal of immunology (Baltimore, Md. : 1950) 20050801 |
| Agonist activity of the small molecule C3aR ligand SB 290157. | Journal of immunology (Baltimore, Md. : 1950) 20050615 |
| Innovative strategies for PBPC mobilization. | Cytotherapy 20050101 |
| Synthetic small-molecule complement inhibitors. | Current opinion in investigational drugs (London, England : 2000) 20041101 |
| Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury. | British journal of pharmacology 20040601 |
| Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow. | Blood 20040315 |
| Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models. | Journal of immunology (Baltimore, Md. : 1950) 20010515 |